Health Canada has issued a public advisory about glatiramer acetate, used to treat relapsing-remitting multiple sclerosis (MS). The agency warned on Aug. 21 that patients taking glatiramer acetate could experience anaphylactic reactions, which “can be fatal and may occur at any point during treatment, from as soon as the first dose to months or even…
Health Canada Issues Anaphylaxis Warning for MS Drug
Canadian Government to Launch National Air Accessibility Summit in May
Wheelchair riders have been vocal about airlines severely damaging their wheelchairs and seating.
Canada’s federal government plans to host its first National Air Accessibility Summit in May in Ottawa. A March 18 news announcement said the summit will be cohosted by Pablo Rodriguez, the Canadian Minister of Transport, and Kamal Khera, the Minister of Diversity, Inclusion and Persons with Disabilities. “The government of Canada continues to work towards…